Skip to main content
OpenTrials

Clinical trial condition

Acquired Immunodeficiency Syndrome

Explore clinical trials studying Acquired Immunodeficiency Syndrome. Study availability and eligibility vary by location and protocol.

2,565 public trials 176 recruiting studies
Refine in advanced search Browse all conditions

Acquired Immunodeficiency Syndrome trial results

Recruiting

REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE

NCT07476339

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +17 more
Locations
  • CAN Community Health Clearwater, Florida, United States
  • Midway Specialty Care Center Ft. Pierce, Florida, United States
  • CAN Community Health Jacksonville, Florida, United States
  • CAN Community Health Orlando, Florida, United States
View Trial Details
Recruiting

A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or ViiV Healthcare-collaborative Parent Studies for HIV Treatment

NCT07393659

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • GSK Investigational Site Durban, KwaZulu-Natal, South Africa
  • GSK Investigational Site Jouberton, Matlosana, South Africa
  • GSK Investigational Site Gauteng, South Africa
  • GSK Investigational Site Johannesburg, South Africa
View Trial Details
Recruiting

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

NCT07071623

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
Locations
  • UW - KNH; Rachuonyo County Hospital ( Site 0006) Homabay County, Homa Bay County, Kenya
  • Partners in Health and Research Development (PHRD) ( Site 0002) Thika, Kiambu County, Kenya
  • KEMRI-CMR-RCTP ( Site 0003) Nairobi, Kisumu County, Kenya
  • Kargeno Research & Policy Hub ( Site 0007) Kisumu, Kenya
View all 30 locations
View Trial Details
Recruiting

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

NCT07044297

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
Locations
  • University of Alabama at Birmingham-UAB 1917 Research Clinic ( Site 0006) Birmingham, Alabama, United States
  • USA Health University Hospitals ( Site 0020) Mobile, Alabama, United States
  • UCLA Center for Clinical AIDS Research and Education ( Site 0004) Los Angeles, California, United States
  • Bridge HIV - San Francisco Department of Public Health ( Site 0001) San Francisco, California, United States
View all 81 locations
View Trial Details

Related conditions